AL
OREX

Airain Ltd’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Airain Ltd’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,744
Closed -$136K – 1268
2015
Q2 		$136K Buy
+2,744
New +$164K 0.01% 797
2015
Q1 		– Sell
-9,619
Closed -$583K – 1100
2014
Q4 		$583K Buy
+9,619
New +$483K 0.05% 364
2013
Q4 		– Sell
-2,999
Closed -$184K – 818
2013
Q3 		$184K Sell
2,999
-1,396
-32% -$94.5K 0.03% 410
2013
Q2 		$257K Buy
+4,395
New +$270K 0.04% 419

Other funds holding OREX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Airain Ltd's OREX Position: Q3 2015 in Review

Airain Ltd sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2015, closing a stake of 2,744 shares — an estimated $136K sold.

Airain Ltd first reported a position in OREX in Q2 2013 and held it in 4 quarters. The position peaked at $583K in Q4 2014. 132 funds tracked by Wall St. Rank hold OREX as of Q3 2015.

  • Airain Ltd reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
  • Airain Ltd sold 2,744 Orexigen Therapeutics, Inc. shares in Q3 2015, an estimated $136K.
  • Airain Ltd first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 4 quarters.
  • Airain Ltd's Orexigen Therapeutics, Inc. position peaked at $583K in Q4 2014.
  • 132 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2015.

Based on Airain Ltd's 13F filing for Q3 2015, filed 9 Nov 2015.